EXPLORING THE MOLECULAR INTRICACIES OF IMMUNE REACTIONS TO NAEGLERIA FOWLERI IN CONJUNCTION WITH GUT MICROBIOTA FOR NOVEL THERAPEUTIC ADVANCEMENTS

Main Article Content

Muhammad Waseem
Aman Qammar
Hamza Altaf
Muneeba Afzal
Ruqaya Shoukat
Tayyaba Faiz
Sobia Mushtaq
Kibria Hassan
Afshan Kiran
Muhammad Sarwar Hayat
Nageen Hussain
Yasir Nawaz

Keywords

Gut Microbiota, humoral immunity, Naegleria fowleri, Outbreaks, Pathogenic Amoeba

Abstract

Introduction: Naegleria fowleri, a pathogenic amoeba found on all continents except Antarctica. It causes are Primary Amoebic Meningoencephalitis (PAM) with 95% fatality rate, predominantly affecting healthy people from all age group. Research on Naegleria's biology and behavior intensified the efforts which helps to develop prevention and treatment strategies. Objectives: To investigate the mechanisms of humoral and innate immunity with molecular characters in arguing for Naegleria fowleri infections in gut microbiota and explore their potential benefits for therapeutic development.


Materials and Methods: Different data bases were used to collect the data for article in systematics pattern. The globally epidemiologically surgery was performed to analyze the risk factor, death rate and consequence of viral load in community especially in gut disease and corresponding infections.


Results: Risk factors which also add the water resources and cultural practice are expressing the main cause of disease spreading the defense mechanism of the human body against viral load involves the participation of both humoral and innate immunity intimate with gut bacterial colonization. The humoral immunity is responsible for producing antibodies target and neutralize pathogenic organism. The innate immunity provides a rapid response to viral infections through the activation of various cells and molecules. This collaboration between the humoral and innate immunity ensures a comprehensive defense against viral load in gut microbiota. The social collaboration among different communities is found an effective agenda to reduce the risk of disease and death rate as well by developing gut infection.


Conclusion: To conclude, the Naegleria Fowleri infections highlights the pressing need for continued vigilance, collaboration and innovation to combat this rare yet lethal disease. Further immunity role and health precaution are necessary element to reduce the effects.

Abstract 167 | Pdf Downloads 56

References

1. Apfelbaum, S. L., K. W. Duvall, T. M. Nelson, D. M. Mensing, H. H. Bengtson, J. Eppich, C. Penhallegon, and R. L. Thompson. *Wetland Water Cooling Partnership: The Use of Constructed Wetlands to Enhance Thermoelectric Power Plant Cooling and Mitigate the Demand of Surface Water Use. * Brodhead, WI (United States): Applied Ecological Services Inc., 2013.
2. Aykur, M., D. Dirim Erdogan, N. Selvi Gunel, A. Guler, C. Biray Avci, N. Celebisoy, C. Gunduz, and H. Dagci. "Genotyping and Molecular Identification of Acanthamoeba Genotype T4 and Naegleria fowleri from Cerebrospinal Fluid Samples of Patients in Turkey: Is it the Pathogens of Unknown Causes of Death?" *Acta Parasitologica* 67 (2022): 1372-1383.
3. Boucher, A., J. Herrmann, P. Morand, R. Buzelé, Y. Crabol, J. Stahl, and A. Mailles. "Epidemiology of Infectious Encephalitis Causes in 2016." *Médecine et Maladies Infectieuses* 47 (2017): 221-235.
4. Carlson, T., E. Lupinacci, K. Moseley, and S. Chandrasekaran. "Effects of Environmental Factors on Sensitivity of Cryptococcus neoformans to Fluconazole and Amphotericin B." *FEMS Microbiology Letters* 368, no. 7 (2021): fnab040.
5. Centers for Disease Control and Prevention. "Naegleria fowleri — Primary Amebic Meningoencephalitis (PAM) — Amebic Encephalitis." *Parasites* (2022).
6. Chao-Pellicer, J., I. Arberas-Jiménez, F. Fuchs, I. Sifaoui, J. E. Piñero, J. Lorenzo-Morales, and P. Scheid. "Repurposing of Nitroxoline as an Alternative Primary Amoebic Meningoencephalitis Treatment." *Antibiotics* 12, no. 8 (2023): 1280.
7. Coronado-Velázquez, D., A. Betanzos, J. Serrano-Luna, and M. Shibayama. "An in vitro model of the blood–brain barrier: Naegleria fowleri affects the tight junction proteins and activates the microvascular endothelial cells." *Journal of Eukaryotic Microbiology* 65, no. 6 (2018): 804-819.
8. De Jonckheere, J. F. "The Impact of Man on the Occurrence of the Pathogenic Free-living Amoeboflagellate Naegleria fowleri." *Future Microbiology* 7 (2012): 5-7.
9. De Jonckheere, J. F. "What do we know by now about the genus Naegleria?" *Experimental Parasitology* 145 (2014): S2-S9.
10. Dos Santos, D. L., B. J. M. Chaúque, V. G. Virginio, V. C. Cossa, C. Pettan-Brewer, H. S. Schrekker, and M. B. Rott. "Occurrence of Naegleria fowleri and their implication for health-a look under the One Health approaches." *International Journal of Hygiene and Environmental Health* 246 (2022): 114053.
11. Ekici, A., S. Alkan, S. Aydemir, E. Gurbuz, and A. H. Unlu. "Trends in Naegleria fowleri global research: A bibliometric analysis study." *Acta Tropica* 234 (2022): 106603.
12. Ferrari, M., E. Sica, F. De Bernardi, A. Luini, M. Legnaro, L. Nosetti, P. Castelnuovo, M. Cosentino, and F. Marino. "Reduction of IL-6, IL-8 and β2-Adrenoceptor mRNA levels in circulating polymorphonuclear leukocytes after adenotonsillectomy in children with Obstructive Sleep Apnea Syndrome." *Sleep Medicine* 114 (2024): 82-85.
13. Fritz-Laylin, L. K., and C. Fulton. "Naegleria: a classic model for de novo basal body assembly." *Cilia* 5 (2016): 1-6.
14. Güémez, A., and E. García. "Primary amoebic meningoencephalitis by Naegleria fowleri: pathogenesis and treatments." *Biomolecules* 11, no. 9 (2021): 1320.
15. Gutiérrez-Sánchez, M., M. M. Carrasco- Yépez, J. Correa-Basurto, G. L. Ramírez-Salinas, and S. Rojas-Hernández. "Two MP2CL5 antigen vaccines from Naegleria fowleri stimulate the immune response against meningitis in the BALB/c model." *Infection and Immunity* 91, no. 7 (2023): 181-223.
16. Humphrey, S., Á. San Millán, M. Toll- Riera, J. Connolly, A. Flor-Duro, J. Chen, C. Ubeda, R. C. MacLean, and J. R. Penadés. "Staphylococcal phages and pathogenicity islands drive plasmid evolution." *Nature Communications* 12 (2021): 5845.
17. Jahangeer, M., Z. Mahmood, N. Munir, U. E. Waraich, I. M. Tahir, M. Akram, S. M. Ali Shah, A. Zulfqar, and R. Zainab. "Naegleria fowleri: Sources of infection, pathophysiology, diagnosis, and management; a review." *Clinical and Experimental Pharmacology and Physiology* 47, no. 2 (2020): 199-212.
18. Ladki, S., and J. Samad. "Summer Recreational Water Tourism: A Deadly Human Encounter with Naegleria fowleri." *J Tourism Hospit* 6 (2017): 2167-0269.1000306.
19. Lupi, O., B. L. Bartlett, R. N. Haugen, L. C. Dy, A. Sethi, S. N. Klaus, J. M. Pinto, F. Bravo, and S. K. Tyring. "Tropical dermatology: tropical diseases caused by protozoa." *Journal of the American Academy of Dermatology* 60 (2009): 897-925.
20. Maciver, S. K., J. E. Piñero, and J. Lorenzo-Morales. "Is Naegleria fowleri an emerging parasite?" *Trends in Parasitology* 36, no. 1 (2020): 19-28.
21. Martínez-Castillo, M., R. Cárdenas-Zúñiga, D. Coronado-Velázquez, A. Debnath, J. Serrano-Luna, and M. Shibayama. "Naegleria fowleri after 50 years: is it a neglected pathogen?" *Journal of Medical Microbiology* 65 (2016): 885.
22. Matanock, A., J. M. Mehal, L. Liu, D. M. Blau, and J. R. Cope. "Estimation of undiagnosed Naegleria fowleri primary amebic meningoencephalitis, United States." *Emerging Infectious Diseases* 24 (2018): 162.
23. Mungroo, M. R., N. A. Khan, and R. Siddiqui. "Naegleria fowleri: diagnosis, treatment options and pathogenesis." *Expert Opinion on Orphan Drugs* 7 (2019): 67-80.
24. Oncel, K., L. Karaagac, H. Dagcı, and M. Aykur. "Real-time PCR confirmation of a fatal case of primary amoebic meningoencephalitis in Turkey caused by Naegleria fowleri or brain-eating amoeba." *Acta Parasitologica* 67 (2022): 697-704.
25. Otero-Ruiz, A., L. D. Gonzalez-Zuñiga, L. Z. Rodriguez-Anaya, L. F. Lares-Jiménez, J. R. Gonzalez-Galaviz, and F. Lares-Villa. "Distribution and current state of molecular genetic characterization in pathogenic free-living amoebae." *Pathogens* 11 (2022): 1199.
26. Rajendran, K., U. Ahmed, A. C. Meunier, M. F. Shaikh, R. Siddiqui, and A. Anwar. "Natural Terpenes Inhibit the Cytopathogenicity of Naegleria fowleri Causing Primary Amoebic Meningoencephalitis in the Human Cell Line Model." *ACS Chemical Neuroscience* 14, no. 23 (2023): 4105-14.
27. Reyes-López, M., G. Ramírez-Rico, J. Serrano-Luna, and M. de la Garza. "Activity of apo-lactoferrin on pathogenic protozoa." *Pharmaceutics* 14 (2022): 1702.
28. Siddiqui, R., and N. A. Khan. "Primary amoebic meningoencephalitis caused by Naegleria fowleri: an old enemy presenting new challenges." *PLoS Neglected Tropical Diseases* 8 (2014): e3017.
29. Reyes-López, M., G. Ramírez-Rico, J. Serrano-Luna, and M. de la Garza. "Activity of apo-lactoferrin on pathogenic protozoa." *Pharmaceutics* 14 (2022): 1702.
30. Siddiqui, R., and N. A. Khan. "Primary amoebic meningoencephalitis caused by Naegleria fowleri: an old enemy presenting new challenges." *PLoS Neglected Tropical Diseases* 8 (2014): e3017.
31. Son, D. H., and S. Y. Jung. "Interaction of Naegleria fowleri Trophozoites with Escherichia coli and MRSA by N-acetylglucosamine and Galactose." *Biomedical Science Letters* 27, no. 4 (2021): 323-328.
32. Wang, X., X. Shang, and X. Huang. "Next- generation pathogen diagnosis with CRISPR/Cas-based detection methods." *Emerging Microbes & Infections* 9, no. 1 (2020): 1682-1691.
33. Wang, H., E. Bedard, M. Prévost, A. K. Camper, V. R. Hill, and A. Pruden. "Methodological approaches for monitoring opportunistic pathogens in premise plumbing: A review." *Water Research* 117 (2017): 68-86.
34. Yoder, J. S., S. Straif-Bourgeois, S. L. Roy, T. A. Moore, G. S. Visvesvara, R. C. Ratard, V. R. Hill, J. D. Wilson, A. J. Linscott, and R. Crager. "Primary amebic meningoencephalitis deaths associated with sinus irrigation using contaminated tap water." *Clinical Infectious Diseases* 55 (2012): e79-e85.

Most read articles by the same author(s)